• Ulcerative colitis is a chronic inflammatory disease that predominantly affects the colonic mucosa. The condition typically follows a relapsing-remitting course and is characterized by the symptoms of abdominal pain and bloody diarrhea. Patients may also experience fatigue, weight loss, and rectal bleeding as well as extraintestinal manifestations. Current therapy is aimed at reducing symptom burden and maintaining disease quiescence. The Advances in Ulcerative Colitis Special Report series is a CME-certified collection of activities that focuses on recent developments and advances in the understanding, assessment, and treatment of this chronic inflammatory bowel disease. Each CME activity includes links to original clinical content, including expert columns, articles, case reports, and literature reviews, all of which are written by leading authorities in the field.

CME Activities

• CME Advances in Ulcerative Colitis - Volume 4Dr. Sandborn discusses maintenance of remission in UC; Drs. Limsui and Pardi address the impact of UC on quality of life; and Dr. Lashner reviews the literature on surgical intervention in UC.
  • Long-term Maintenance of Remission in Ulcerative Colitis
    William J. Sandborn, MD (Expert Column, March 28, 2008)
  • Quality of Life in Ulcerative Colitis
    David Limsui, MD; Darrell S. Pardi, MD (Clinical Focus, March 28, 2008)
  • Surgical Intervention in Ulcerative Colitis
    Bret A. Lashner, MD (Literature Review, March 28, 2008)
• CME Advances in Ulcerative Colitis - Volume 3Dr. Lashner discusses issues in CRC chemoprevention in UC; Dr. Velayos explores strategies in management of quiescent UC; and Drs. Leung and Hanauer review the literature on colorectal cancer in UC.
  • Ulcerative Colitis and Colorectal Cancer Chemoprevention
    Bret A. Lashner, MD (Expert Column, December 14, 2007)
  • Strategies to Prevent Colorectal Cancer in Quiescent Ulcerative Colitis
    Fernando S. Velayos, MD, MPH (Case Report, December 14, 2007)
  • Colorectal Cancer and Ulcerative Colitis
    Yvette Leung, MD; Stephen B. Hanauer, MD, FACG (Literature Review, December 14, 2007)
• CME Advances in Ulcerative Colitis - Volume 2Drs. Levy and Siegel discuss issues in adherence to 5-ASA therapy in UC; Dr. Binion reviews patients' experiences living with UC; and Dr. Lashner reviews the literature on the role of bacteria in UC.
  • Adherence Issues in the Treatment of Ulcerative Colitis
    L. Campbell Levy, MD; Corey A. Siegel, MD (Expert Column, September 28, 2007)
  • Patients' Experiences Living With Ulcerative Colitis
    David G. Binion, MD (Clinical Focus, September 28, 2007)
  • Bacterial Interactions in Ulcerative Colitis Patients
    Bret A. Lashner, MD (Literature Review, September 28, 2007)
• CME Advances in Ulcerative Colitis - Volume 1Drs. Gross and Kornbluth discuss the importance of mucosal healing in UC; Drs. Leighton and Pasha review the role of endoscopy; and Bret Lashner, MD, reviews the literature on therapy for UC.
  • Mucosal Healing as an Efficacy Parameter in Mild-to-Moderate Ulcerative Colitis
    Rebekah G. Gross, MD; Arthur Asher Kornbluth, MD (Expert Column, August 30, 2007)
  • The Role of Endoscopy in Ulcerative Colitis: Old Facts and New Advances
    Shabana F. Pasha, MD; Jonathan A. Leighton, MD (Clinical Focus, August 30, 2007)
  • Advances in the Treatment of Ulcerative Colitis
    Bret A. Lashner, MD (Literature Review, August 30, 2007)